RxDoctor Payments Data

Nkese Williams-Hayes

Psychiatric/Mental Health · Hopewell, VANPI 1013625177

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (58.1%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. AbbVie accounts for 67.2% of it on its own, with 14 other manufacturers making up the rest. 2025 is the largest year on record at $11,619, 9.4 times the $1,231 reported in 2023. Among psychiatric/mental health clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$15,497in general payments, 2019–2025

Across 260 payments — averaging $59.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$10K
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$2K
  • Supernus Pharmaceuticals, Inc.$871
  • Teva Pharmaceuticals USA, Inc.$657
  • Vanda Pharmaceuticals Inc.$346
  • Axsome Therapeutics, Inc.$312
  • plus $977 from 9 others

What the payments were for

  • Speaking & faculty fees$9,00058%
  • Travel & lodging$1141%
  • Food & beverage$6,37441%
  • Education$80%

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$15,497 in reported general payments places this provider in the 95th percentile of 1,003 psychiatric/mental health providers in Virginia.

See all psychiatric/mental health providers in Virginia

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl26$37,314
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine85$2,639
Alprazolam159$847
Ziprasidone Hcl26$784
Prazosin Hcl42$679
Venlafaxine Hcl ErVenlafaxine Hcl44$595
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine17$567
Aripiprazole33$396
Bupropion XlBupropion Hcl40$348
Mirtazapine40$348
Buspirone Hcl33$287
Duloxetine Hcl25$285
Trazodone Hcl65$270
Clozapine12$246
Clonazepam35$223

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$10,410$37,31426 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,003 psychiatric/mental health providers in Virginia.

Other psychiatric/mental health in Hopewell

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →